Free Trial

Edwards Lifesciences (EW) Competitors

Edwards Lifesciences logo
$75.68 -1.23 (-1.60%)
Closing price 07/24/2025 03:59 PM Eastern
Extended Trading
$82.00 +6.32 (+8.35%)
As of 07:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EW vs. HSIC, AMN, BSX, SYK, MDT, BDX, IDXX, RMD, DXCM, and STE

Should you be buying Edwards Lifesciences stock or one of its competitors? The main competitors of Edwards Lifesciences include Henry Schein (HSIC), AMN Healthcare Services (AMN), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "medical" sector.

Edwards Lifesciences vs. Its Competitors

Henry Schein (NASDAQ:HSIC) and Edwards Lifesciences (NYSE:EW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

96.6% of Henry Schein shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 1.1% of Henry Schein shares are held by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Edwards Lifesciences has lower revenue, but higher earnings than Henry Schein. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Henry Schein$12.67B0.70$390M$3.2022.69
Edwards Lifesciences$5.52B8.04$4.17B$7.0010.81

Edwards Lifesciences has a net margin of 75.48% compared to Henry Schein's net margin of 3.21%. Edwards Lifesciences' return on equity of 16.62% beat Henry Schein's return on equity.

Company Net Margins Return on Equity Return on Assets
Henry Schein3.21% 14.87% 5.82%
Edwards Lifesciences 75.48%16.62%12.64%

Henry Schein currently has a consensus price target of $78.36, indicating a potential upside of 7.91%. Edwards Lifesciences has a consensus price target of $81.37, indicating a potential upside of 7.52%. Given Henry Schein's higher probable upside, research analysts plainly believe Henry Schein is more favorable than Edwards Lifesciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
0 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.36
Edwards Lifesciences
1 Sell rating(s)
11 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.50

Henry Schein has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500.

In the previous week, Edwards Lifesciences had 28 more articles in the media than Henry Schein. MarketBeat recorded 36 mentions for Edwards Lifesciences and 8 mentions for Henry Schein. Edwards Lifesciences' average media sentiment score of 0.86 beat Henry Schein's score of 0.67 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Edwards Lifesciences
19 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Edwards Lifesciences beats Henry Schein on 13 of the 17 factors compared between the two stocks.

Get Edwards Lifesciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EW vs. The Competition

MetricEdwards LifesciencesMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$45.12B$6.94B$5.73B$21.15B
Dividend YieldN/A1.28%4.60%3.58%
P/E Ratio10.8125.4327.9827.76
Price / Sales8.0449.72451.3458.40
Price / Cash28.1720.6736.5523.00
Price / Book4.444.728.644.67
Net Income$4.17B$176.14M$3.24B$993.85M
7 Day Performance-1.00%3.35%3.69%1.48%
1 Month Performance-1.65%3.91%10.34%5.79%
1 Year Performance26.76%8.55%34.32%11.41%

Edwards Lifesciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EW
Edwards Lifesciences
4.4427 of 5 stars
$75.68
-1.6%
$81.37
+7.5%
-13.0%$45.12B$5.52B10.8115,800Trending News
Earnings Report
High Trading Volume
HSIC
Henry Schein
3.7011 of 5 stars
$69.07
0.0%
$78.36
+13.5%
+3.3%$8.41B$12.67B21.5825,000
AMN
AMN Healthcare Services
4.2338 of 5 stars
$18.52
-6.6%
$32.08
+73.3%
-68.2%$708.83M$2.98B-4.282,968
BSX
Boston Scientific
4.623 of 5 stars
$103.85
+0.2%
$116.04
+11.7%
+36.5%$153.65B$16.75B75.8153,000Trending News
Earnings Report
Analyst Forecast
SYK
Stryker
4.5217 of 5 stars
$387.58
-0.5%
$428.55
+10.6%
+16.6%$147.94B$22.60B52.3853,000Positive News
Upcoming Earnings
MDT
Medtronic
4.6524 of 5 stars
$89.76
+0.2%
$98.19
+9.4%
+15.5%$115.12B$33.54B24.8095,000Positive News
BDX
Becton, Dickinson and Company
4.7677 of 5 stars
$175.49
-1.9%
$219.22
+24.9%
-22.6%$50.30B$20.18B33.4974,000Positive News
Dividend Announcement
Insider Trade
IDXX
IDEXX Laboratories
3.6126 of 5 stars
$520.87
+1.2%
$560.33
+7.6%
+16.7%$41.89B$3.90B48.1411,000Positive News
RMD
ResMed
3.6486 of 5 stars
$261.10
+1.2%
$263.00
+0.7%
+32.6%$38.28B$5.02B29.309,980Positive News
Upcoming Earnings
DXCM
DexCom
4.7595 of 5 stars
$84.03
+0.2%
$99.60
+18.5%
-22.5%$32.95B$4.03B62.7110,300Upcoming Earnings
STE
STERIS
4.8475 of 5 stars
$222.55
-1.3%
$266.50
+19.7%
-1.9%$21.89B$5.46B35.9017,787Analyst Forecast

Related Companies and Tools


This page (NYSE:EW) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners